CEU Statement: Use of double dose (3mg) levonorgestrel emergency contraception by women taking enzyme-inducing medications
Date: 02 Jul 2016
Type: FSRH Clinical Guidance and Clinical Statements
Author: FSRH CEU
This statement is a CEU response to the European Medicines Agency (EMA) recommendation on the use of levonorgestrel emergency contraception (LNG-EC) by woman taking a medication that induces hepatic enzymes.
The European Medicines Agency has recommended that the dose of levonorgestrel emergency contraception (LNG-EC) should be doubled to 3mg if a woman is taking a medication that induces hepatic enzymes (and for four weeks after discontinuation of an enzyme-inducing medication). This is in line with current FSRH guidelines and the British National Formulary (BNF).
Please refer to the current FSRH Guideline Emergency Contraception for more information on this. The link is below.